SunRegen Healthcare AG is a biopharmaceutical company with a mission to develop drugs to treat neurodegenerative diseases. We focus on innovative treatments for patients suffering from neurological, neuromuscular and ophthalmic diseases. Our first product candidates in development target primary optical atrophy. We are further evaluating them for use in serious neurological / neuromuscular diseases such as ALS, Huntington’s, Alzheimer’s and Parkinson’s disease.
SunRegen
